- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Bloomberg reported that Molycorp (OTCMKTS:MCPIQ) has gained permission to put itself up for auction in March.
Bloomberg reported on Friday that Molycorp (OTCMKTS:MCPIQ) has gained permission to put itself up for auction in March.
As quoted in the publication:
Molycorp filed for bankruptcy in June after rare earth prices dropped, making its California mine unprofitable. The company’s processing division, which sells rare earths from lower-cost mines in China, remains profitable. Rare earths are elements used in devices including magnets for electric cars and wind turbines.
After about two months in mediation with creditors, Molycorp resolved disputes over auction rules that had threatened a sale. Proceeds from an auction would go toward repaying more than $500 million that Oaktree’s seeking and more than $1.4 billion senior and junior bondholders say they’re owed.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.